Influence of perfusate temperature on nasal potential difference

European Respiratory Journal

Volumn 42, Issue 2, 2013, Pages 389-393

  Bronsveld, Inez ^a   Vermeulen, Francois ^b   Sands, Dorotha ^c   Leal, Teresinha ^d   Leonard, Anissa ^d   Melotti, Paola ^e   Yaakov, Yasmin ^f   De Nooijer, Roel ^a   De Boeck, Kris ^b   Sermet, Isabelle ^g   Wilschanski, Michael ^f   Middleton, Peter G ^h  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Dept of Pediatrics ^*  (Poland)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e UNIVERSITY HOSPITAL OF VERONA   (Italy)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; ISOPRENALINE; RINGER SOLUTION;

ADOLESCENT; ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; METABOLIC PARAMETERS; NASAL POTENTIAL DIFFERENCE; PERFUSATE TEMPERATURE; PERFUSION; PRIORITY JOURNAL; REPRODUCIBILITY; ROOM TEMPERATURE; TEMPERATURE; TEMPERATURE SENSITIVITY; WARMING;

ADOLESCENT; ADULT; AMILORIDE; CHLORIDE CHANNELS; CHLORIDES; CYSTIC FIBROSIS; HEALTHY VOLUNTEERS; HUMANS; ION TRANSPORT; IONS; ISOPROTERENOL; MIDDLE AGED; NASAL MUCOSA; PERFUSION; TEMPERATURE; TIME FACTORS; YOUNG ADULT;

EID: 84874721444     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00097712     Document Type: Article

References (13)

1. De Boeck K, Derichs N, Fajac I, et al. New clinical diagnostic procedures for cystic fibrosis in Europe. J Cyst Fibros 2011; 10: Suppl. 2, S53-S66.
2. Middleton PG, House HH. Measurement of airway ion transport assists the diagnosis of cystic fibrosis. Pediatr Pulmonol 2010; 45: 789-795.
3. Accurso FJ, Rowe SM, Clancy JP, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 2010; 363: 1991-2003.
4. Kerem E, Hirawat S, Armoni S, et al. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 2008; 372: 719-727.
5. Knowles M, Gatzy J, Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 1981; 305: 1489-1495.
6. Rowe SM, Clancy JP, Wilschanski M. Nasal potential difference measurements to assess CFTR ion channel activity. Methods Mol Biol 2011; 741: 69-86.
7. Standaert TA, Boitano L, Emerson J, et al. Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials. Pediatr Pulmonol 2004; 37: 385-392.
8. Middleton PG, Geddes DM, Alton EW. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J 1994; 7: 2050-2056.
9. Boyle MP, Diener-West M, Milgram L, et al. A multicenter study of the effect of solution temperature on nasal potential difference measurements. Chest 2003; 124: 482-489.
10. House HH, Middleton PG. Impact of different chloride and glucose solutions on nasal potential difference. Pediatr Pulmonol 2009; 44: 645-648.
11. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995; 6: 445-455.
12. Vermeulen F, Proesmans M, Feyaerts N, et al. Nasal potential measurements on the nasal floor and under the inferior turbinate: does it matter? Pediatr Pulmonol 2011; 46: 145-152.
13. Liener K, Leiacker R, Lindemann J, et al. Nasal mucosal temperature after exposure to cold, dry air and hot, humid air. Acta Otolaryngol 2003; 123: 851-856.